NCT07248891Enrolling by invitation
Type 2 Diabetes and Associated Factors in Mexico
Comprehensive Study of Associated Factors With Type 2 Diabetes in Mexico: Protocol
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
The goal of this observational cross-sectional multicenter study is to identify clinical, lifestyle, metabolic, inflammatory, and genetic factors associated with glycemic control and complications of Type 2 Diabetes (T2D) in adult patients in Mexico. The main questions it aims to answer are: Which molecular and clinical factors are associated with poor glycemic control (HbA1c \> 7%)? Which factors are linked to the presence of diabetic nephropathy (GFR \< 60 mL/min/1.73 m²)? Participants: Provide informed consent and clinical history. Undergo a clinical and physical evaluation (including six-minute walk test). Complete lifestyle, dietary, and therapeutic adherence questionnaires. Provide blood samples for biochemical, inflammatory, and transcriptomic (RNA-Seq) analysis. Researchers integrate clinical, biochemical, and transcriptomic data using statistical modeling to identify a characteristic molecular fingerprint of poor metabolic control and diabetes-related complications.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 1 Apr 2025
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Coordinación de Investigación en Salud, Mexico
- Diseases
- Chronic kidney disease, Type 2 diabetes
- NCT number
- NCT07248891
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Apr 2025 to the primary completion date, 30 Dec 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of steroids
- Concomitant illness with inflammatory or autoimmune component (rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriatic arthritis, gout).
- History of cerebrovascular disease, heart failure or kidney failure that required hospitalization in the previous month.
- History of infection in the previous 10 days (respiratory tract infection, gastroenteritis, urinary tract infection, soft tissue infection).
Other illness
- Severe obesity with BMI \> 40 kg/m2. History of bariatric surgery.
Other
- Pregnant or lactating mother
- Tobacco use (in the last 3 months).
Who the study is looking for
- Adults 18 years of age or older.
- Established diagnosis of Type 2 Diabetes Mellitus (T2D).
- Patients receiving care at Family Medicine Units in Coahuila, Jalisco, or Veracruz.
- Willingness to voluntarily participate in the study.
- Ability to understand the study procedures and provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Mexicano del Seguro Social Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
| Coordinación de Investigación en Salud Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
| División de Investigación en Salud Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.